Churchill Capital Corp. filed for a $400 million IPO very late Friday evening, with a focus on the technology and software sectors. Churchill is being led by Jerre Stead, as CEO and Director, and Michael Klein, as Chairman. This SPAC team has quite a few impressive names, from top to bottom.
In addition to Mr. Stead, who is the former Chairman and CEO of IHS Markit Ltd. (Nasdaq:INFO), and Mr. Klein, who is currently a Director of Credit Suisse and the Founder and Managing Partner of M. Klein and Company, the team includes a former member of President Barack Obama’s Cabinet (Karen Mills) and former Chairman of British Airways (Sir Martin Broughton). You can read the team’s full bios here.
This is another big SPAC from Citigroup on the heels of the $552 million Spartan Energy Acquisition Corp. However, given that Michael Klein is a Director of Credit Suisse, it’s surprising Credit Suisse is not an underwriter. Maybe they will be added at a later date or maybe there’s a conflict of interest I’m missing, but the absence was noted.
As far as structure, Churchill follows the typical Tier-1 structures found on the NYSE, except, instead of one-third of one warrant, the unit will be offering one-half of one warrant. The sponsor, which is an affiliate of M. Klein and Company, will be purchasing 12,500,000 warrants at $1.00 for total at-risk capital of $12.5 million (before over-allotment). Full summary of terms below.
Churchill Capital Corp. Summary of Terms:
- Focus: Technology / Software
- Size: $400 million
- 100% held in trust ($10.00 per share)
- $10.00 unit comprised of one share of Class A Common Stock + 1/2 of one Warrant
- Warrant call for redemption threshold: equals or exceeds $18.00 (cash or cashless exercise)
- 24 months to complete an acquisition
- Limitation on Redemption Rights: 15%
- At-risk Capital: $12.5 million (12,500,000 warrants at $1.00)
- Underwriter fees: 2.0% + 3.5% deferred.
Citigroup is sole book-runner.
Paul, Weiss, Rifkind, Wharton & Garrison LLP and Winston & Strawn LLP are Issuer’s Counsel and Underwriter’s Counsel, respectively.
At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...
Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...
At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...
Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...
At the SPAC of Dawn Ever since Digital World announced its combination with Trump Media (NASDAQ:DJT) back in October 2021, it was clear that SPACworld and the Trump show were set to be intertwined for quite some time. And, although not every headline has a bearing on the wider SPAC world, Trump Media’s post-close rise...